These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12003248)

  • 1. Diagnosis of preclinical Alzheimer's disease in a clinical setting.
    Visser PJ; Verhey FR; Ponds RW; Jolles J
    Int Psychogeriatr; 2001 Dec; 13(4):411-23. PubMed ID: 12003248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.
    Visser PJ; Verhey FR; Scheltens P; Cruts M; Ponds RW; Van Broeckhoven CL; Jolles J
    J Neurol; 2002 Mar; 249(3):312-9. PubMed ID: 11993532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between preclinical Alzheimer's disease and depression.
    Visser PJ; Verhey FR; Ponds RW; Kester A; Jolles J
    J Am Geriatr Soc; 2000 May; 48(5):479-84. PubMed ID: 10811539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of educational background on verbal fluency task performance in older adults with Alzheimer's disease and mild cognitive impairment.
    Kawano N; Umegaki H; Suzuki Y; Yamamoto S; Mogi N; Iguchi A
    Int Psychogeriatr; 2010 Sep; 22(6):995-1002. PubMed ID: 20602860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.
    Koppel J; Goldberg TE; Gordon ML; Huey E; Davies P; Keehlisen L; Huet S; Christen E; Greenwald BS
    Am J Geriatr Psychiatry; 2012 Nov; 20(11):994-1000. PubMed ID: 22048323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting.
    Smith T; Gildeh N; Holmes C
    Can J Psychiatry; 2007 May; 52(5):329-32. PubMed ID: 17542384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.
    Rasquin SM; Lodder J; Visser PJ; Lousberg R; Verhey FR
    Dement Geriatr Cogn Disord; 2005; 19(2-3):113-9. PubMed ID: 15591801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semantic memory impairment in the earliest phases of Alzheimer's disease.
    Vogel A; Gade A; Stokholm J; Waldemar G
    Dement Geriatr Cogn Disord; 2005; 19(2-3):75-81. PubMed ID: 15572875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cognitive impairment in subjects with geriatric depression who will develop Alzheimer's disease and other dementias: a retrospective study.
    Jean L; Simard M; van Reekum R; Clarke DE
    Int Psychogeriatr; 2005 Jun; 17(2):289-301. PubMed ID: 16050437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment: clinical characterization and outcome.
    Petersen RC; Smith GE; Waring SC; Ivnik RJ; Tangalos EG; Kokmen E
    Arch Neurol; 1999 Mar; 56(3):303-8. PubMed ID: 10190820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can frontotemporal dementia and Alzheimer's disease be differentiated using a brief battery of tests?
    Gregory CA; Orrell M; Sahakian B; Hodges JR
    Int J Geriatr Psychiatry; 1997 Mar; 12(3):375-83. PubMed ID: 9152724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological differentiation between Alzheimer's disease and dementia with Lewy bodies in a memory clinic.
    Kawai Y; Miura R; Tsujimoto M; Sakurai T; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Kachi T; Toba K
    Psychogeriatrics; 2013 Sep; 13(3):157-63. PubMed ID: 25913764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.
    Doraiswamy PM; Kaiser L; Bieber F; Garman RL
    Alzheimer Dis Assoc Disord; 2001; 15(4):174-83. PubMed ID: 11723368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.